GSA Capital Partners »

Neuropace shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $562k 55k 10.31
2025-06-30 $593k 53k 11.14
2025-03-31 $677k 55k 12.29
2024-12-31 $631k 56k 11.19